Data presented today at the World Diabetes Congress of the International Diabetes Federation (IDF) show that adults with type 2 diabetes achieved improved glycaemic control, significantly lower rates of overall and nocturnal confirmed hypoglycaemia for the full trial period, and a significantly lower rate of severe hypoglycaemia during the maintenance period (defined as week 16 onwards) with Ryzodeg® compared to biphasic insulin aspart 30, both administered twice-daily1.
Ryzodeg® is the first combination of two distinct insulin analogues, Tresiba® (insulin degludec), the once-daily basal insulin with an ultra-long duration of action, and the well-established mealtime insulin NovoRapid® (insulin aspart), in the ratio of 70% and 30%, in one pen for people with type 2 diabetes2-4.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64158-ryzodeg-improved-glycaemic-control
As back to school season approaches, Pilot Corporation of America (Pilot Pen) is working diligently to help empower students to excel and to overcome their greatest challenges during the school year. Bullying and cyberbullying are at an all time high, with nearly 1 out of 4 U.S. students having been bullied. Pilot Pen’s ongoing partnership with the nation’s leading anti-bullying prevention organization, STOMP Out Bullying is designed to help “Erase Bullying For Good,” for the fourth consecutive year. The goal of this campaign is to raise awareness of this serious issue, helping to ensure that parents, educators and students are aware of the valuable resources available to those in need of support. As part of the effort, Pilot is donating 10 cents from every specially-marked package of FriXion Clicker erasable gel ink pens purchased during the back to school period, to support STOMP Out Bullying. Pilot is committed to donating $325,000 to the organization.
To view the multimedia release go to:
https://www.multivu.com/players/English/8342451-pilot-pen-stomp-out-erase-bullying-for-good/
